DECK Q1 2026 Earnings EPS Surpasses Estimates by 1337 aTyr Pharma Q1 2026 Earnings NarrowerThanExpected Loss Provides Some Relief Amid Pipeline Development PHVS Q1 2026 Earnings NarrowerThanExpected Loss as Biotech Advances HAE Pipeline HTGC Q1 2026 Earnings Slight EPS Miss as Investment Income Holds Steady Cheche Group Q4 2024 Earnings Narrowed Loss Beats Estimates Despite Stock Decline PMTU Q1 2026 Earnings EPS Falls Short of Expectations Revenue Data Unavailable